Proteomics to Identify Prognostic Markers After CPR and to Estimate Neurological Outcome

Completed

• Conditions: Cardiac Arrest

• Registration Number: NCT02247947
• Lead Sponsor: Universitätsklinikum Köln

Brief Summary

Proteomics is used to identify prognostic markers after CPR. Additionally neurological outcome should be estimated by specific protein alterations and affections of pathways.

Detailed Description

Proteomics is used to identify prognostic markers after CPR, i.e. altered proteins on a 2G-gel. Additionally neurological outcome should be estimated by specific protein alterations and affections of pathways.

Study Timeline

• Study Start: 2014-09
• Study First Submitted: 2014-09-20
• Study First Submitted QC: 2014-09-20
• Study First Posted: 2014-09-25
• Status Verified: 2020-11
• Primary Completion: 2020-11-01
• Study Completion: 2020-11-01
• Last Update Submitted: 2020-11-03
• Last Update Posted: 2020-11-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• cardiac arrest

Exclusion Criteria

• trauma

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
death at day 20	day 20

Trial Locations

Locations (1)

University Hospital of Cologne; 🇩🇪 Cologne, NRW, Germany